Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2003
02/13/2003WO2003012427A1 Hematology control product with increased closed vial stability
02/13/2003WO2003012426A1 Lytic reagent composition for determination of nucleated red blood cells
02/13/2003WO2003012423A1 Hollow fiber having inner wall into which comb polymer is introduced, hollow fiber impregnated with gel, and fiber array thin section
02/13/2003WO2003012421A1 Analyzing implement, analyzing device, and method of manufacturing analyzing implement
02/13/2003WO2003012418A1 Particle count correction method and apparatus
02/13/2003WO2003012416A1 Method of determining presence and concentration of lipoprotein x in blood plasma and serum
02/13/2003WO2003012413A2 Determining water content and droplet size of a water-in-oil emulsion by means of two resonators operating at different frequencies
02/13/2003WO2003012411A1 Method of evaluating uniformity of spots in arrays
02/13/2003WO2003012410A1 Method for detecting at a solid support of complexing or hybridization between at least two basic molecules based on an amplified at the support
02/13/2003WO2003012400A1 Non-destructive joint sealant testing device
02/13/2003WO2003012397A1 Microorganism-collecting chip, microorganism-collecting kit, method of quantifying microorganisms, specimen for confirming normal state of microorganism-quantifying apparatus and microorganism-quantifying apparatus
02/13/2003WO2003012396A2 Immune complexes
02/13/2003WO2003012395A2 Early detection of mycobacterial disease using peptides
02/13/2003WO2003012393A2 Method of detecting protease activity in a cell
02/13/2003WO2003012390A2 Methods and devices for detecting hydrocarbons and petroleum products
02/13/2003WO2003012389A2 Method for analysing macromolecules, analysis device and a method for producing an analysis device
02/13/2003WO2003012378A1 Level and density measurement using gamma radiation
02/13/2003WO2003012146A1 Modular assembly of nucleic acid-protein fusion multimers
02/13/2003WO2003012140A1 Method of analyzing nucleic acid specifying gene showing change in expression dose in schizophrenia
02/13/2003WO2003012138A1 Method of screening pis for resistance to salmonellosis
02/13/2003WO2003012137A2 Methods for detecting parkinson's disease
02/13/2003WO2003012131A2 Assays for protease inhibitors, methods and means
02/13/2003WO2003012127A2 Assay for identifying inhibitors of hiv rt dimerization
02/13/2003WO2003012126A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
02/13/2003WO2003012125A2 Mre11: modulation of cellular proliferation
02/13/2003WO2003012124A2 Methods for immobilizing molecules to a solid phase and uses thereof
02/13/2003WO2003012122A2 Crystallized structure of type iv collagen nc1 domain hexamer
02/13/2003WO2003012118A1 Complexity management of genomic dna
02/13/2003WO2003012108A2 Uses of a thyx polypeptide or a nucleic acid encoding such a polypeptide, in particular for screening anti-bacterial or anti-viral compounds
02/13/2003WO2003012107A1 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof
02/13/2003WO2003012105A2 Vegf isoform
02/13/2003WO2003012104A1 Novel g protein-coupled receptor protein and dna thereof
02/13/2003WO2003012093A2 Regulator of calcineurin
02/13/2003WO2003012089A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
02/13/2003WO2003012087A1 Cell line for screening ligand or ligand-like low-molecular weight compound
02/13/2003WO2003012078A2 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
02/13/2003WO2003012077A1 Method for preventing the adhesion of particles
02/13/2003WO2003012069A2 Compositions and methods for generating chimeric heteromultimers
02/13/2003WO2003012068A2 Novel fusion proteins and assays for molecular binding
02/13/2003WO2003012067A2 Expression profile of prostate cancer
02/13/2003WO2003012064A2 Nucleic acids and encoded polypeptides associated with bipolar disorder
02/13/2003WO2003012055A2 Sak: modulation of cellular proliferation for treatment of cancer
02/13/2003WO2003012047A2 Isolation of membrane bound ligand-specific complexes
02/13/2003WO2003012043A2 Enhancing organ maturity in neonates and predicting their duration of intensive care
02/13/2003WO2003012042A2 Ratio-based oligonucleotide probe selection
02/13/2003WO2003012041A2 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit
02/13/2003WO2003012034A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
02/13/2003WO2003012026A1 Apparatus and method for determining the onset and presence of sepsis conditions
02/13/2003WO2003011906A2 Use of peptide fragments of the calcium channel α-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest
02/13/2003WO2003011898A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
02/13/2003WO2003011464A1 Magnetical vessel centering system and method
02/13/2003WO2003011451A1 Cell isolation and screening device and method of using same
02/13/2003WO2003011395A2 Method of utilizing neurotrophins to manipulate reproductive capacity
02/13/2003WO2003011338A1 Regulation of gastric acid secretion by inwardly rectifying k+ channels
02/13/2003WO2003011330A1 Membrane vesicles of biological fluid sampled in vivo, their preparation and use in stimulating an immune response
02/13/2003WO2003011328A1 Pregnancy-related enzyme activity
02/13/2003WO2003011326A1 Use of long pentraxin ptx3 for treating female infertility
02/13/2003WO2003011325A1 Agonists and antagonists of moceptin for the treatment of metabolic disorders
02/13/2003WO2003011324A1 Agonists and antagonists of moxifin for the treatment of metabolic disorders
02/13/2003WO2003011323A1 Agonists and antagonists of contabix for use in the treatment of metabolic disorders
02/13/2003WO2003011322A1 Agonists and antagonists of genoxin for use in the treatment of metabolic disorders
02/13/2003WO2003011321A1 Agonists and antagonists of cobesin for the treatment of metabolic disorders
02/13/2003WO2003011320A1 Agonists and antagonists of obesingen for the treatment of metabolic disorders
02/13/2003WO2003011319A1 Xobesin agonists and antagonists for the treatment of metabolic disorders
02/13/2003WO2003011318A1 Agonists and antagonists of famoset for use in the treatment of metabolic disorders
02/13/2003WO2003011317A1 Modulators of notch signalling for use in immunotherapy
02/13/2003WO2003011304A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity
02/13/2003WO2003011271A2 Methods and compositions for modulating brain damage
02/13/2003WO2003011251A1 Pulmonary formulation
02/13/2003WO2003011209A2 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes
02/13/2003WO2003011144A1 Intra-vaginal self-administered cell collecting device and method
02/13/2003WO2003011142A1 Method and device for predicting the fertile phase of women
02/13/2003WO2003011119A2 Methods and compositions for diagnosis and treatment of vascular conditions
02/13/2003WO2003011118A2 Human zona pellucida proteins and methods of their use in diagnosing male infertility
02/13/2003WO2003011019A2 Lethal mouse model for testing of pharmaceuticals and vaccines against neospororis
02/13/2003WO2002101388A3 Assay for predeicting cell activity
02/13/2003WO2002097054A3 Shaped microcomponents via reactive conversion of biologically-derived microtemplates
02/13/2003WO2002095403A3 Method for determining the binding behaviour of ligands which specifically bind to target molecules
02/13/2003WO2002092007A3 Screening methods for pathogen virulence factors under low oxygen conditions.
02/13/2003WO2002079749A3 System and method for generating a profile of particulate components of a body fluid sample
02/13/2003WO2002079228A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
02/13/2003WO2002078848A8 Holding device, particularly for body fluids, comprising a separating device, and a separating device therefor
02/13/2003WO2002069907A3 Anti-neovasculature preparations for cancer
02/13/2003WO2002069232A3 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity
02/13/2003WO2002066067A3 Albumin-based drug delivery system and antimicrobial peptides
02/13/2003WO2002064038A3 System for evaluating data obtained in a biochip measurement device
02/13/2003WO2002060584A3 Method for carrying out a biochemical protocol in continuous flow in a microreactor
02/13/2003WO2002059567A3 Lateral flow testing device with on-board chemical reactant
02/13/2003WO2002059368A8 Specific mucin expression as a marker for pancreatic cancer
02/13/2003WO2002055556A3 Regulation of human voltage gated potassium channel protein kv2.2
02/13/2003WO2002053723B1 Degradation and detection of tse infectivity
02/13/2003WO2002051434A3 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
02/13/2003WO2002047460A3 Mass spectrometric multivariate analysis of asphalts
02/13/2003WO2002046750A3 Methods of predicting chemotherapy response
02/13/2003WO2002046722A3 Method for diagnosing pathology in biological samples
02/13/2003WO2002046466A3 Complexes of brca and stat polypeptides and methods of use in the detection and treatment of cancer
02/13/2003WO2002044731A3 Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays
02/13/2003WO2002044330A3 Crystal structure of rotavirus nsp4 peptide
02/13/2003WO2002043765A9 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
02/13/2003WO2002040996A8 Differential gene expression in specific regions of the brain in neurodegenerative diseases
1 ... 2653 2654 2655 2656 2657 2658 2659 2660 2661 2662 2663 2664 2665 2666 2667 2668 2669 2670 2671 2672 2673 ... 3937